Medical/Pharmaceuticals
Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital
LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN), today announced its wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acquisition...
Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry
Viva Biotech is acknowledged for its pioneering AI-driven drug discovery
platforms that accelerate timelines, reduce costs, and expand therapeutic
innovation in the global pharmaceutical R&D ecosystem.
SAN ANTONIO, Sept. 29, 2025 /PRNewswire/ -- Frost & Sullivan
Chula ARi Pilots Model Communities to Address Thailand's Aging Boom
BANGKOK, Sept. 29, 2025 /PRNewswire/ -- Chula ARi,
NYSE Content Advisory: Pre-Market Update + Wall Street digests August PCE data
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + Wall Street digests ...
COREE Announces Discovery of Microbiome Biomarkers Specific to Diabetes and Obesity Patients
* Joint research achievement by Gemelli Hospital in Rome, COREE, COREE Pohang, and the Università Cattolica del Sacro Cuore SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific...
Tescan acquires FemtoInnovations and launches Laser Technology Business Unit
TAIPEI, Sept. 26, 2025 /PRNewswire/ -- Tescan Group today announced the acquisition ofFemtoInnovations, a leading innovator in ultrafast laser technologies, and the creation of a dedicatedLaser Technology Business Unit (LT BU) headquartered at the University of Connecticut (UConn) Tech Park. The ...
CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
FILSPARI® (sparsentan) suggested for IgA Nephropathy patients who are at risk of progressive kidney function loss ST. GALLEN, Switzerland, and SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical...
Get Race-Ready for KLSCM 2025 with Pantai Hospital Kuala Lumpur
A Hospital That Runs With You KUALA LUMPUR, Malaysia, Sept. 26, 2025 /PRNewswire/ -- As the countdown begins to the Kuala Lumpur Standard Chartered Marathon (KLSCM) 2025, thousands of runners are training hard to hit their personal bests. But while most are focused on mileage, timing, and gear, ...
Tourism Malaysia and MHTC Bring Malaysia Fair 2025 to Surabaya A Celebration of Culture, Cuisine, Travel, and Healthcare Excellence
SURABAYA, Indonesia, Sept. 26, 2025 /PRNewswire/ -- Tourism Malaysia, in collaboration with the Malaysia Healthcare Travel Council (MHTC), proudly presents Malaysia Fair 2025—a four-day celebration ofMalaysia's culture, cuisine, tourism, and healthcare excellence. Taking place at Pakuwon Mall, Su...
Catalent Announces Opening of its New Global Corporate Headquarters in Tampa, Florida
Relocation reflects a strategic expansion in Florida alongside long-standing manufacturing facility in nearby St. Petersburg New headquarters designed to support innovation, collaboration and growth TAMPA, Fla., Sept. 26, 2025 /PRNewswire/ -- Catalent, Inc., the leader in enabling the developmen...
Building a National Lung Cancer Screening Model with AI: Early Lessons from Australia
BRISBANE, Australia and SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ --
Coreline Soft
iotaMotion Surpasses 1,000 Clinical Procedures Performed with iotaSOFT® --Defining a New Era in Cochlear Implant Surgery
* Fewer than 5% of eligible patients worldwide receive cochlear implants today * Hearing loss is the largest modifiable risk factor for dementia, linked to approximately 8% of global cases — more than hypertension, obesity, smoking, or depression ST. PAUL, Minn., Sept. 25, 2025 /PRNewswire/ -- ...
C2F Empowers Chula to Advance Academic Excellence and Research on the Path to Becoming a World-Class University
BANGKOK, Sept. 25, 2025 /PRNewswire/ -- The C2F, or Second Century Fund
Sky Labs Launches CART BP, a Ring-Type Cuffless Blood Pressure Monitor
App-based "Blood Pressure Calendar" enables 24-hour tracking, including
nighttime measurements
SEOUL, South Korea, Sept. 25, 2025 /PRNewswire/ -- Sky Labs announced the
official launch of CART BP, a ring-type personal blood pressure monitor
designed for everyday use.
ADVANCION PUBLISHES 2024 CORPORATE SUSTAINABILITY REPORT
Fourth annual report highlights continued progress in sustainable innovation, safety, and responsible resource stewardship BUFFALO GROVE, Ill., Sept. 25, 2025 /PRNewswire/ -- Advancion Corporation ("Advancion" or "Company"), a global leader in life science buffers and proprietary specialty ingre...
Suvoda and Greenphire complete brand integration with unified website and social media presence
CONSHOHOCKEN, Pa., Sept. 25, 2025 /PRNewswire/ -- Suvoda LLC
MindHYVE.ai™ Unveils ChironAI™: The World's First AGI-Powered Clinical Decision Support System, Redefining Healthcare Intelligence
NEWPORT BEACH, Calif., Sept. 24, 2025 /PRNewswire/ -- HYVE Labs™ and MindHYVE.ai™ proudly announce the global launch of ChironAI™, an autonomous, next-generation Clinical Decision Support (CDS) system powered by the revolutionary Ava-Healthcare™ AGI reasoning model. Designed from the ground up t...
The Hidden Genetic Threat Putting 1 in 5 at Cardiovascular Disease Risk: Global Experts Call for Action on Elevated Lipoprotein(a)
* Cardiovascular disease (CVD) kills nearly 18 million people each year, more than all cancers combined1,2 * Elevated lipoprotein(a) or Lp(a), an inherited condition that raises CVD risk, affects 1 in 5 people worldwide but is rarely tested3 * New survey across Asia Pacific and Middle East s...
Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811)
SHANGHAI, Sept. 24, 2025 /PRNewswire/ -- Hengrui Pharma (600276.SH; 01276.HK), a leading innovative global pharmaceutical company focused on scientific and technological innovation, announced today that it has entered into an exclusive license agreement with Glenmark Specialty S.A. (GSSA), a whol...
Xinhua Silk Road: Guotai Haitong Securities hosts conference on biopharma and AI in E. China's Shanghai
BEIJING, Sept. 24, 2025 /PRNewswire/ -- The 2025 Shanghai pioneering industries conference, hosted by Guotai Haitong Securities, was recently held in east China's Shanghai. The event also featured the 14th pharmaceutical CEO forum and the 5th artificial intelligence (AI) conference. The event bro...
Week's Top Stories
Most Reposted
DBS is First Bank in Asia Pacific to Pilot Visa Intelligent Commerce for Everyday Payments
[Picked up by 319 media titles]
2026-02-16 10:00Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 317 media titles]
2026-02-19 14:30Little Artists Art Studio, Singapore Shines at Art Capital 2026
[Picked up by 277 media titles]
2026-02-17 19:12Kung Fu Meets Spring -- Unitree Spring Festival Gala Robots Present "Cyber Real Kung Fu" in the Year of the Horse
[Picked up by 256 media titles]
2026-02-17 14:16SMU MBA Rises in FT Global Rankings, Excelling in ESG, Salary and Value-for-Money
[Picked up by 250 media titles]
2026-02-16 08:00